Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ADORA3 | P0DMS8 | 3/20 | 0.47 |
| ▸ | ADORA1 | P30542 | 2/20 | 0.47 |
| ▸ | ADORA2A | P29274 | 1/20 | 0.47 |
| ▸ | DPP4 | P27487 | 1/20 | 0.46 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.43 |
| ▸ | LMNA | P02545 | 1/20 | 0.43 |
| ▸ | GAA | P10253 | 1/20 | 0.43 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.43 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.43 |
| ▸ | MEN1 | O00255 | 2/20 | 0.43 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.43 |
| ▸ | HPGD | P15428 | 3/20 | 0.41 |
| ▸ | NPSR1 | Q6W5P4 | 3/20 | 0.41 |
| ▸ | ATM | Q13315 | 2/20 | 0.40 |
| ▸ | PDE5A | O76074 | 2/20 | 0.40 |
| ▸ | ABCG2 | Q9UNQ0 | 1/20 | 0.40 |
| ▸ | EGFR | P00533 | 1/20 | 0.39 |
| ▸ | NR1H2 | P55055 | 1/20 | 0.38 |
| ▸ | NR1H3 | Q13133 | 1/20 | 0.38 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL18553253 | 1.00 | ADORA3 (0.47) | ADORA3ADORA1ADORA2ADPP4KDM4E | |
| SCHEMBL18553259 | 0.99 | ADORA3 (0.46) | ADORA3ADORA1ADORA2ADPP4KDM4E | |
| SCHEMBL18017830 | 0.93 | MEN1 (0.45) | ADORA3ADORA1ADORA2ADPP4KDM4E | |
| SCHEMBL18017816 | 0.93 | MEN1 (0.45) | ADORA3ADORA1ADORA2ADPP4KDM4E | |
| SCHEMBL18017822 | 0.93 | MEN1 (0.45) | ADORA3ADORA1ADORA2ADPP4KDM4E | |
| SCHEMBL18370746 | 0.92 | MEN1 (0.44) | ADORA3ADORA1ADORA2ADPP4KDM4E | |
| SCHEMBL18017828 | 0.92 | MEN1 (0.44) | ADORA3ADORA1ADORA2ADPP4KDM4E | |
| SCHEMBL18370716 | 0.92 | MEN1 (0.44) | ADORA3ADORA1ADORA2ADPP4KDM4E | |
| SCHEMBL18017835 | 0.92 | MEN1 (0.44) | ADORA3ADORA1ADORA2ADPP4KDM4E | |
| SCHEMBL18017839 | 0.92 | MEN1 (0.44) | ADORA3ADORA1ADORA2ADPP4KDM4E |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11299459-B2 | Compound for organic electric element, organic electric element comprising the same and electronic device thereof | DUK SAN NEOLUX CO., LTD. (KR) | 2022-04-12 | — | — | US | disclosed |
| US-10934308-B2 | Compound for organic electronic element, organic electronic element using same, and electronic device comprising same | DUK SAN NEOLUX CO., LTD. (KR) | 2021-03-02 | — | — | US | disclosed |
| WO-2017048025-A1 | COMPOUND FOR ORGANIC ELECTRONIC ELEMENT, ORGANIC ELECTRONIC ELEMENT USING SAME, AND ELECTRONIC DEVICE COMPRISING SAME | 덕산네오룩스 주식회사 | 2017-03-23 | — | — | WO | disclosed |
| WO-2017030307-A1 | COMPOUND FOR ORGANIC ELECTRONIC ELEMENT, ORGANIC ELECTRONIC ELEMENT USING SAME, AND ELECTRONIC APPARATUS COMPRISING SAME | 덕산네오룩스 주식회사 | 2017-02-23 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11299459-B2 | Compound for organic electric element, organic electric element comprising the same and electronic device thereof | PIEZO1, OCIAD1, TMEM109 | ADORA3 4728/4885ADORA1 3855/4885ADORA2A 4795/4885 |
| US-10934308-B2 | Compound for organic electronic element, organic electronic element using same, and electronic device comprising same | OR51E2, NFE2L2, ETV6 | ADORA3 4558/4885ADORA1 4135/4885ADORA2A 4272/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.